BioSpace News Archive

Xencor, Inc. (NASDAQ: XNCR) today announced that clinical data from expansion cohorts in its Phase 1 study of plamotamab, a CD20 x CD3 bispecific antibody, in patients with relapsed or refractory non-Hodgkin’s lymphoma will be presented in a poster session during the 64th American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana on Monday, December 12, 2022.

Accelus today announced that the U.S. Food & Drug Administration (FDA) had cleared Accelus’s 510(k) application for its Remi™ Robotic Navigation System software update that allows image capture with the GE OEC 3D, Ziehm Vision RFD 3D, and Stryker Airo TruCT systems.

Vincerx Pharma, Inc. announced three poster presentations at the upcoming 64th American Society of Hematology Annual Meeting 2022, being held virtually and in New Orleans, Louisiana from December 10-13, 2022.

Nurix Therapeutics, Inc. announced that its clinical-stage BTK degrader programs will be featured in two oral presentations and one poster presentation at the 64th American Society of Hematology Annual Meeting and Exposition being held December 10-13, 2022 in New Orleans, LA.

NeuroMetrix, Inc. announced the strategic launch of its Quell® Fibromyalgia device through the Pathfinder Program.

Trinity Biotech plc announced the Company’s results for the quarter ended June 30, 2022 and preliminary guidance with respect to Q3 revenues.

Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients, today announced that it will make three presentations relating to its ongoing clinical trials at the 2022 American Society of Hematology (ASH) Annual Meeting.

AcelRx Pharmaceuticals, Inc. today announced that it will release third quarter financial results after market close on Monday, November 14, 2022.

KeifeRx, LLC announced today that its Chief Executive Officer Chris Hoyt will present at BioFuture 2022 being held November 7-9, 2022.